Andy Kuo

16PUBLICATIONS
33CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)PharmacogenomicsMedical bacteriologyBiologically active moleculesComputational chemistry
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Aug 10, 2026
An NLRP3 inflammasome inhibitor evoked dose-dependent anti-allodynia in the hindpaws of a rat model of chemotherapy-induced peripheral neuropathy.

|Feb 16, 2026
Preclinical Pharmacokinetics and Pharmacodynamics of Antibiotic Adjuvants.

Viet Tin Pham, David M P De Oliveira, Andy Kuo

|Apr 11, 2025
Florasulam Is a Potent Inhibitor of Mycobacterium tuberculosis Acetohydroxyacid Synthase and Possesses In Vivo Antituberculosis Activity.

Shun Jie Wun, Lendl Tan, Thierry G Lonhienne

|Dec 22, 2023
seco-1-Azacubane-2-carboxylic Acid: Derivative Scope and Comparative Biological Evaluation.

Dehui Kong, Tyler Fahrenhorst-Jones, Andy Kuo

|May 12, 2023
In Vitro Assessment of the Metabolic Stability of Two Novel Endomorphin-2 Analogs, CYX-5 and CYX-6, in Rat Liver Microsomes.

Mohammad Zafar Imam, Sussan Ghassabian, Andy Kuo

|Mar 01, 2023
Multitargeted Opioid Ligand Discovery as a Strategy to Retain Analgesia and Reduce Opioid-Related Adverse Effects.

Maree T Smith, Dehui Kong, Andy Kuo

Pageof 3

Frequent Collaborators

16 joint publications

Maree T Smith

5 joint publications

Mohammad Zafar Imam

4 joint publications

Craig M Williams

3 joint publications

Sussan Ghassabian